MyFinsight
Home
Blog
About
Back
Cash Flow
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN)
source: myfinsight.com
Net proceeds from
the issuance of...
$4,035,000
Net proceeds from
the issuance of...
$794,844
Net cash provided by
financing activities
$4,829,844
Net (decrease)
increase in cash
-$3,237,969
Canceled cashflow
$4,829,844
Accounts payable and
accrued liabilities
$711,391
Stock-based compensation to
employees, directors and...
$707,527
Depreciation expense
$110,740
Net cash used in
operating activities
-$8,067,813
Canceled cashflow
$1,529,658
Net loss
-$8,772,382
Prepaid expenses and
other current assets
$825,089
Back